Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AIOctober 27, 2026

XBI SPDR S&P Biotech ETF

Fund tearsheet · data as of the latest session · October 27, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$10.4Bfund assets
+23.4%return, YTD
—return, 1 year
+$534Mnet flow, 1 month
+$1.3Bnet flow, 1 year
28.9%realized volatility, 1y
-14.9%worst drawdown, 1y
Top ten holdings
1MRNA MODERNA1.41%
2TWST TWIST BIOSCIENCE1.40%
3IOVA IOVANCE BIOTHERAPEUTICS0.56%
4GRAL GRAIL INC0.90%
5NTRA NATERA1.16%
6HALO HALOZYME THERAPEUTICS1.03%
7KYMR KYMERA THERAPEUTICS1.35%
8ORKA Oruka Therapeutics1.37%
9KOD KODIAK SCIENCES0.54%
10REGN REGENERON PHARMACEUTICALS0.96%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.